First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2013-08-31 16:13:56Open Document File Size: 163,61 KBShare Result on FacebookCityNucleoside / Heidelberg / Kerr / /CompanyGWAS / John Wiley & Sons Inc. / HP / Proc Natl Acad Sci U S A / International Transporters Consortium / /CountryGermany / /Currencypence / /EventFDA Phase / /FacilityPflugers Arch / University of Western Ontario / /IndustryTermnonfunctional product / protein product / carrier mechanisms / pharmacogenomics technologies / solute carrier transporter function / solute carrier / expression systems / energy / /MedicalConditioncancer / JE / HIV / disease / breast cancer / /MedicalTreatmentantibiotics / drug therapy / /NaturalFeatureWheeler MT / /OrganizationUniversity of Western Ontario / US Food and Drug Administration / RI AL / /PersonRichard B. Kim / DeGorter / Ho / /PositionMedical Research Chair / Jones PM / /ProductProbenecid / cyclosporine / Acyclovir / Dipyridamole / gemfibrozil / Cimetidine / repaglinide / fexofenadine / furosemide / losartan / Key drug / /ProgrammingLanguageABC / /PublishedMediumPLoS One / /RadioStationGeorge AM / /RegionWestern Ontario / /Technologygenomics / pharmacokinetics / Pharmacogenomic / ion exchange / functional genomics / DRUG DISCOVERY / pharmacogenetics / pharmacogenomics technologies / diagnostic tests / SNP / genotyping / simulation / drug development / human genome / /SocialTag |